Incidence Of Hepatitis In Intensive Care Unit
- Conditions
- Intensive Care Unit
- Registration Number
- NCT03456037
- Lead Sponsor
- Sakarya University
- Brief Summary
The aim is to investigate incidence of HBsAg, anti-HCV in serum samples and evaluation of biomarkers taken from patients who were followed the intensive care unit of Sakarya University Training and Research Hospital and The intensive care unit attracts attention by making health workers more susceptible to the risk of hepatitis.
- Detailed Description
This retrospective study included 536 cases who were followed with various diagnoses in intensive care units between 1 Ocak 2015 ile 1 Ocak 2016, covering the six months period, retrospectively. Sakarya University's Faculty of Medicine Review Board (71522473/050.01.04/113) approved the study after approval of the research ethics committee (. Medical record forms and electronic medical record system of the hospital were used in the analysis of medical data with regard to age, sex, HBsAg, anti-HCV, AST, ALT, bilirubin, creatinine levels.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
All patients who were followed in the intensive care unit
None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBsAg 1 month HBsAg is the serologic hallmark of HBV infection and is the first marker to appear after acute infection.
- Secondary Outcome Measures
Name Time Method anti-HCV 1mounth Anti-HCV antibody tests look for antibodies to HCV in the blood, indicating an HCV infection has occurred.
Trial Locations
- Locations (1)
Sakarya University Research and Training Hospital
🇹🇷Sakarya, Turkey